13-Month-Old Boy Diagnosed with Cancer-Like Illness After Doctors Initially Mistook Rash for Psoriasis

A toddler from England, Sonny Hook, is undergoing chemotherapy and steroid treatment after a series of misdiagnoses led to a late diagnosis of Langerhans cell histiocytosis (LCH), a rare and serious condition resembling cancer. His mother, Emma Hook, has been vocal about her experience navigating the healthcare system in search of answers for her son’s deteriorating health.

Born in January 2025, Sonny was initially diagnosed with human papillomavirus (HPV) and psoriasis shortly after birth when a red rash appeared on his skin. Following this diagnosis, he was discharged from King’s Mill Hospital in Nottinghamshire, which is operated by Sherwood Forest Hospitals NHS Trust. However, over the following months, Emma noticed further troubling symptoms that prompted her to seek a second opinion.

By April 2025, just four months after his birth, Sonny was developing persistent ear infections, cradle cap, and increasingly severe open sores in various parts of his body, including under his neck, in his armpits, and around his groin. Emma, distressed by his worsening state, insisted on a referral to an ear, nose, and throat (ENT) specialist. “Everything just kept getting worse and worse until I hit breaking point,” Emma recounted in an interview, expressing her frustration with the healthcare process.

Despite her insistence that the treatments prescribed were ineffective, Sonny was initially continued on a course meant for psoriasis by the dermatologist. The situation escalated until he was finally referred to an oncology department at Queen’s Medical Centre (QMC) in Nottingham, where the correct diagnosis of LCH was made when he was 10 months old.

LCH occurs when Langerhans cells, a type of immune system cell, accumulate excessively in the body, leading to potential damage to tissues and the formation of tumours. It is recognised as a rare condition that can significantly impact a child’s health and wellbeing. Following his diagnosis, Sonny has undergone multiple rounds of chemotherapy aimed at addressing the LCH present in his lymph nodes and is now on a steroid treatment regimen administered every three weeks for his skin and ear issues.

In response to the concerns raised by Emma regarding his treatment journey, a spokesperson for Sherwood Forest Hospitals expressed regret about the challenges she faced and reaffirmed their commitment to improving patient care and safety.

To help cover the costs associated with Sonny’s ongoing treatment, a GoFundMe campaign has been initiated. Emma has also taken the initiative to organise an Easter egg event for other children receiving treatment at QMC, highlighting her desire to support other families in similar circumstances. She shared her heartfelt sentiments in a recent Facebook post stating, “No parent ever imagines they’ll find themselves sitting on a children’s cancer ward with their baby — but sadly that’s where our journey has taken us.”

Emma’s journey has underscored the emotional toll of battling a serious health issue and illuminated the need for parents to advocate for their children’s health. “Seeing my boy face such huge battles … really shows just how strong and inspirational these children truly are,” she noted. She encouraged other parents to trust their instincts regarding their child’s health, acknowledging that navigating the healthcare system can be daunting. “Nobody should have to fight doctors, but unfortunately, you have to sometimes,” she remarked.

As Sonny continues his treatment, his story serves as a poignant reminder of the importance of vigilance in the face of health challenges, particularly in young children. Emma’s advocacy for her son’s health and her commitment to supporting others exemplify the resilience often found in families facing similar struggles. The community response to their situation reflects a growing awareness of rare diseases and the need for thorough and timely diagnoses within the healthcare system.